To systematically review the role of (18)F-fluorodeoxyglucose ((18)F-FDG) positron emission tomography (PET) in evaluating treatment response to imatinib or other drugs in gastrointestinal stromal tumors (GIST).
Treglia, G., Mirk, P., Stefanelli, A., Rufini, V., Giordano, A., Bonomo, L., (18)F-Fluorodeoxyglucose positron emission tomography in evaluating treatment response to imatinib or other drugs in gastrointestinal stromal tumors: a systematic review, <<CLINICAL IMAGING>>, 2012; 36 (3): 167-175. [doi:10.1016/j.clinimag.2011.08.012] [http://hdl.handle.net/10807/3072]
(18)F-Fluorodeoxyglucose positron emission tomography in evaluating treatment response to imatinib or other drugs in gastrointestinal stromal tumors: a systematic review
Treglia, Giorgio;Mirk, Paoletta;Stefanelli, Antonella;Rufini, Vittoria;Giordano, Alessandro;Bonomo, Lorenzo
2012
Abstract
To systematically review the role of (18)F-fluorodeoxyglucose ((18)F-FDG) positron emission tomography (PET) in evaluating treatment response to imatinib or other drugs in gastrointestinal stromal tumors (GIST).
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
